With 0.72 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.19 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.5501 whereas the lowest price it dropped to was $1.5. The 52-week range on NNVC shows that it touched its highest point at $3.59 and its lowest point at $1.00 during that stretch. It currently has a 1-year price target of $6.50. Beta for the stock currently stands at 0.90.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NNVC was up-trending over the past week, with a rise of 3.38%, but this was up by 19.53% over a month. Three-month performance surged to 5.52% while six-month performance fell -19.90%. The stock gained 44.34% in the past year, while it has gained 50.00% so far this year.
Float and Shares Shorts:
At present, 14.06 million NNVC shares are outstanding with a float of 13.78 million shares on hand for trading. On 2024-10-31, short shares totaled 0.34 million, which was 243.00002000000003 higher than short shares on 1727654400. In addition to Dr. Anil R. Diwan Ph.D. as the firm’s Executive Chairman, President, CEO & Secretary, Ms. Meeta R. Vyas B.S., M.B.A., MBA, SB serves as its CFO & Compliance Officer.
Institutional Ownership:
Through their ownership of 0.09422 of NNVC’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-06-30, NNVC reported revenue of $0.0 and operating income of -$3167834.0. The EBITDA in the recently reported quarter was -$2931198.0 and diluted EPS was -$0.23.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NNVC since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
Analysts have provided yearly estimates in a range of -$0.68478 being high and -$0.80627 being low. For NNVC, this leads to a yearly average estimate of -$0.74. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
